Research and Development

Showing 15 posts of 9607 posts found.

Pfizer in break up talks for Sandwich research site

March 1, 2011 Research and Development Kent, Pfizer, Sandwich, job cuts

Pfizer is in confidential talks over the future of its Sandwich, Kent research facility that could see the site broken …

Service Insight: Discovery metrics – creating the right balance

February 28, 2011 Research and Development Atkinson Cowan, Kinapse, Service Insight, metrics, research and development

SERVICE INSIGHTMetrics can be powerful tools for driving performance in organisations and have proliferated in the pharmaceutical industry over the …
viiv_gsk_pfizer_david_redfern

David Redfern appointed ViiV chairman

February 28, 2011 Research and Development, Sales and Marketing David Redfern, GSK, GlaxoSmithKline, Pfizer, ViiV, ViiV Healthcare, appointment, research and development, sales and marketing

David Redfern has been appointed as chairman of ViiV Healthcare, the joint GlaxoSmithKline-Pfizer venture focused on HIV.

Vertex’s cystic fibrosis drug shows huge promise

February 28, 2011 Research and Development, Sales and Marketing VX-770, Vertex, cystic fibrosis

US pharma company Vertex has announced extremely promising results for a drug that could be a major advance in treating …

New agreement seeks to speed up UK research

February 25, 2011 Research and Development BIA, Industry Collaborative Research Agreement, MRC, Medical Research Council, National Institute for Health Research, Office for Clinical Research Infrastructure, UK research, clinical research, mICRA

The government has revised the research contracting process in a bid to streamline research between pharma and biotech companies, universities …
Pfizer research Sandwich, Kent

MPs to question Pfizer management over R&D closure

February 25, 2011 Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee, research and development

Senior Pfizer executives will appear before MPs next week to answer questions on the closure of the company’s Kent research …

Glioblastoma vaccine enters phase II

February 24, 2011 Research and Development Cancer, GBM, ImmunoCellular Therapeutics, oncology

The first patient has been enrolled in a phase II trial of ICT-107, a cancer vaccine candidate for the treatment …
Roche building

Roche pulls out of vaccine alliance with Transgene

February 23, 2011 Research and Development HPV, HPV vaccine, Roche, TG4001, Transgene, cervical cancer, cervical lesions, human papilloma virus, vaccines

Roche has terminated its license agreement with Transgene for its HPV therapeutic vaccine TG4001. The vaccine is currently being tested …

Online international research register launched

February 23, 2011 Research and Development CRD, Centre for Reviews and Dissemination, Department of Health, NIHR, National Institute for Health Research, Prospero, clinical research, health research register

The UK government has backed the creation of a free, international online register to improve the transparency of health research. …
Lung cancer cells

No magic bullet, but a growing arsenal against lung cancer

February 23, 2011 Research and Development ASA404, Cancer, Iressa, NSCLC, Tarceva, afatinib, crizotinib, figitumumab, lung cancer, non small cell lung cancer, non-small cell lung cancer

A man in his 70s is waiting for his appointment with the oncologist after being referred there by his family …

J&J hepatitis C drug begins phase III trials

February 23, 2011 Research and Development J&J, JJ, Johnson and Johnson, TMC435, Tibotec, hepatitis, hepatitis C

Johnson & Johnson has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the …

Contract research news in brief

February 23, 2011 Research and Development Bioanalytical Systems, Evotec, Iris Pharma, Kancera, Kinaxo Biotechnologies, NSF International, Pharmalytica Services, iNovacia

Acquisitions by Evotec, Kancera and NSF International head our latest CRO news round-up, along with updates from BASi and Iris …
ge_healthcare_kieran_murphy

Kieran Murphy to head up life sciences for GE Healthcare

February 23, 2011 Research and Development, Sales and Marketing GE Healthcare, Kieran Murphy, appointment, research and development, sales and marketing

GE Healthcare has promoted Kieran Murphy to succeed its current Life Sciences president and chief executive Peter Ehrenheim. Kieran, who …

Sanofi partners on dengue vaccine awareness

February 22, 2011 Medical Communications, Research and Development Dengue Vaccine Institute, Dengue fever, International Vaccine Institute, Sanofi Pasteur, Sanofi-Aventis, disease awareness, vaccines

Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …

Scottish biotech ProStrakan sold for £292m

February 22, 2011 Research and Development KHK, Kyowa Hakko Kirin, ProStrakan, Scottish biotech, biotech

Scottish biotech ProStrakan is to be bought by Japanese manufacturer Kyowa Hakko Kirin for £292 million. The companies agreed the …
The Gateway to Local Adoption Series

Latest content